We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.04B
AUM Growth
+$592M
Cap. Flow
+$104M
Cap. Flow %
1.48%
Top 10 Hldgs %
25.28%
Holding
3,464
New
246
Increased
2,311
Reduced
619
Closed
193

Top Buys

Rank Stock Value
1
DPZ icon
Domino's
DPZ
+$80.7M
2
DE icon
Deere & Co
DE
+$69.7M
3
WM icon
Waste Management
WM
+$50.2M
4
AFL icon
Aflac
AFL
+$48.2M
5
FERG icon
Ferguson
FERG
+$45.6M

Top Sells

Rank Stock Value
1
MO icon
Altria Group
MO
+$77.2M
2
VLO icon
Valero Energy
VLO
+$60.5M
3
AVY icon
Avery Dennison
AVY
+$56.8M
4
CVX icon
Chevron
CVX
+$52.3M
5
UNH icon
UnitedHealth
UNH
+$51.3M

Sector Composition

Rank Sector Weight
1 Technology 25.18%
2 Financials 17.96%
3 Industrials 12.2%
4 Healthcare 9.59%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULBI icon
3326
Ultralife
ULBI
$106M
-157
Closed -$845
UP icon
3327
Wheels Up
UP
$198M
-5
Closed -$93
URG
3328
Ur-Energy
URG
$556M
-916
Closed -$617
VERU icon
3329
Veru
VERU
$37.4M
-69
Closed -$339
VRA icon
3330
Vera Bradley
VRA
$98.7M
-441
Closed -$992
VRCA icon
3331
Verrica Pharmaceuticals
VRCA
$87.3M
-2
Closed -$8
VTSI icon
3332
VirTra
VTSI
$34.5M
-11
Closed -$45
VTYX
3333
DELISTED
Ventyx Biosciences
VTYX
-1,092
Closed -$1.26K
X
3334
DELISTED
US Steel
X
-12,387
Closed -$523K
XBIT icon
3335
XBiotech
XBIT
$69.2M
-358
Closed -$1.16K
XFOR icon
3336
X4 Pharmaceuticals
XFOR
$460M
-6
Closed -$41
ZNTL icon
3337
Zentalis Pharmaceuticals
ZNTL
$302M
-1,027
Closed -$1.63K
ZURA icon
3338
Zura Bio
ZURA
$566M
-53
Closed -$68
ZYXI
3339
DELISTED
Zynex
ZYXI
-16
Closed -$35
FBLG icon
3340
FibroBiologics
FBLG
$6.5M
-1
Closed -$23
ANRO icon
3341
Alto Neuroscience
ANRO
$1.11B
-161
Closed -$348
GUTS icon
3342
Fractyl Health
GUTS
$111M
-237
Closed -$282
STI icon
3343
Solidion Technology
STI
$61.3M
0
-$2
KYTX icon
3344
Kyverna Therapeutics
KYTX
$484M
-186
Closed -$359
MGX icon
3345
Metagenomi Therapeutics
MGX
$46.3M
-190
Closed -$258
TELO icon
3346
Telomir Pharmaceuticals
TELO
$79.8M
-148
Closed -$478
SMXT icon
3347
Solarmax Technology
SMXT
$21.6M
-302
Closed -$362
QTTB icon
3348
Q32 Bio
QTTB
$464M
-105
Closed -$173
GCTS
3349
GCT Semiconductor Holding
GCTS
$235M
-8
Closed -$13
BOLD
3350
Boundless Bio
BOLD
$65M
-119
Closed -$180

Similar funds

Sterling Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Sterling Capital Management held 3,464 positions worth $7.04B, up 9.2% from $6.45B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sterling Capital Management's Q2 2025 filing shows 246 new, 2,311 increased, 619 reduced and 193 closed positions. Its largest new stake was AngloGold Ashanti: 37,656 shares worth $1.72M. The largest sale was Altria Group, an estimated $77.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Sterling Capital Management's largest Q2 2025 buy was AngloGold Ashanti: 37,656 shares worth $1.72M.
  • Sterling Capital Management added most to Domino's in Q2 2025, an estimated $80.7M increase.
  • Sterling Capital Management's biggest Q2 2025 reduction was Altria Group, cutting an estimated $77.2M.
  • Sterling Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $2.38M.
  • Sterling Capital Management's ten largest holdings make up 25% of its $7.04B portfolio in Q2 2025.
  • Sterling Capital Management opened 246 new positions and closed 193 in Q2 2025.
  • Sterling Capital Management's portfolio value rose 9.2% quarter-over-quarter to $7.04B.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.